首页> 外文期刊>Internal medicine. >Donepezil-induced Cervical Dystonia in Alzheimer's Disease: A Case Report and Literature Review of Dystonia due to Cholinesterase Inhibitors
【24h】

Donepezil-induced Cervical Dystonia in Alzheimer's Disease: A Case Report and Literature Review of Dystonia due to Cholinesterase Inhibitors

机译:多奈哌齐诱发阿尔茨海默氏病的宫颈肌张力障碍:胆碱酯酶抑制剂引起的肌张力障碍的一例病例报道和文献综述。

获取原文
获取原文并翻译 | 示例
           

摘要

We herein report an 81-year-old woman with Alzheimer's disease (AD) in who donepezil, a cholinesterase inhibitor (ChEI), caused cervical dystonia. The patient had a two-year history of progressive memory disturbance fulfilling the NINCDS-ADRDA criteria for probable AD. Mini-Mental State Examination score was 19/30. The remaining examination was normal. After a single administration of donepezil (5 mg/day) for 10 months, she complained of dropped head. Neurological examination and electrophysiological studies supported a diagnosis of cervical dystonia. Antecollis disappeared completely at 6 weeks after cessation of donepezil. Dystonic posture can occur at various timings of ChEI use. Physicians should pay more attention to rapidly progressive cervical dystonia in ChEI-treated AD patients.
机译:我们在此报告了一位患有阿尔茨海默氏病(AD)的81岁妇女,其胆碱酯酶抑制剂(ChEI)多奈哌齐引起宫颈肌张力障碍。该患者有两年进行性记忆障碍的病史,符合可能的AD的NINCDS-ADRDA标准。迷你精神状态考试成绩为19/30。其余检查正常。一次服用多奈哌齐(5 mg /天)10个月后,她抱怨头下降。神经学检查和电生理研究支持了宫颈肌张力障碍的诊断。多奈哌齐停止后第6周,前Antecollis完全消失。在使用ChEI的各种时间可能会发生肌张力异常。在ChEI治疗的AD患者中,医师应更加注意快速进行性宫颈肌张力障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号